- Dicembre 14, 2020
Arizona CPAs apply to pharmacists and individual practitioners designated by law as “providers.” Providers include established doctors or nurses. The CPA must indicate the conditions of the disease, the medications, the conditions of notification of the supplier and the laboratory tests that the pharmacist can order. Pharmacists may monitor or modify a patient`s drug treatment in accordance with CPA, provided that the provider and pharmacist have a reciprocal patient-practitioner relationship with the patient.  Ohio pharmacists will soon be able to provide direct patient care services as part of the extension of Practice Cooperation Agreements (CPAs) with physicians. For pharmacists, I think you have reached one of the few crossroads that will determine the future of your profession. You will either be your place as a health care provider, or your numbers will decrease, as most donation activities will be replaced by robotics and pharmacy technicians. I am a doctor, and I say that our profession and the patients we serve need you “as a team” as pharmacists. But are you really going to join us?  Legal guidelines and requirements for the constitution of the CPA are defined on the basis of the state.  The federal government approved the CPAs in 1995.  Washington was the first state to pass laws allowing formal formation of CPAs.
In 1979, Washington changed the practice of pharmaceutical requirements that provide for the formation of “collaborative drug therapy agreements.” [Citation required] Since February 2016, 48 states and Washington D.C have passed laws that allow the availability of CPAs.  The only two states that do not allow cpAs to be made available are Alabama and Delaware.  Alabama pharmacists hoped that a CPA law, House Bill 494, would be passed in 2015.  The bill was introduced by Alabama House Of Representatives Representative Ron Johnson, but died in committee.  CPAs have been implemented for the management of a wide variety of chronic disease conditions, including diabetes mellitus, asthma and hypertension. There is evidence that CP A has shown positive health outcomes for the patients involved. Pharmacists working with CPA providers have been shown to contribute to providing better quality of care in the oncology environment, including the treatment of anti-vomiting treatments.